Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2006Journal of Clinical Oncology

High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

GIGerald IllerhausKlinikum StuttgartRMReinhard MarksUniversity of FreiburgGIGabriele IhorstUniversity of Freiburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Illerhaus et al. (2006) studied this question.

synapsesocial.com/papers/6a71ec2e87f921057128653ahttps://doi.org/10.1200/jco.2006.06.2117
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The massachusetts general hospital experience 1958-19891994 · 334 citations
  2. 2German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphoma2002 · 181 citations
  3. 3Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma2000 · 238 citations
  4. 4Successful Treatment of Non-Hodgkin's Lymphoma of the Central Nervous System with BMPD Chemotherapy Followed by Radiotherapy1998 · 21 citations
  5. 5Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support2004 · 341 citations